7篇
您的检索式：作者名="Patrick LB"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Compensatory hepatic regenera- tion after mild, but not fulminant, intraperitoneal sepsis in rat 显示文摘 | Yoram G Weiss LB Patrick KK | 2001 | Am J Physiol Gastrointest Liver Physio12001，280，： | 1 |
| 2 | Patient re- ported outcomes to support medical product labeling claims : FDA perspective显示文摘 | Patrick DL Burke LB Powers JH | 2007 | Value Health2007，10，2： | 1 |
| 3 | Advances in primary central nervous system lymphoma显示文摘 | Patrick LB Mohile NA | 2015 | Curr Oncol Rep2015，17，12： | 1 |
| 4 | The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient- reported outcomes显示文摘 | Mokkink LB Terwee CB Patrick DL | 2010 | J Clin Epidemiol2010，63，7： | 1 |
| 5 | The COSMIN study reached international consensus on taxonomy, ter- minology, and definitions of measurement properties for health-related patient-reported outcomes显示文摘 | Mokkink LB Terwee CB Patrick DL | 2010 | J Clin Epide miol2010，63，6： | 1 |
| 6 | Advances in Primary Central Nervous System Lymphoma显示文摘 | Patrick LB Mohile NA | 2015 | Curr Oncol Rep2015，17，： | 1 |
| 7 | 原发性中枢神经系统淋巴瘤的研究进展(英文)显示文摘Primary central nervous system lymphoma( PCNSL) is a rare form of non- Hodgkin lymphoma that is limited to the CNS. Although novel imaging techniques aid in discriminating lymphoma from other brain tumors,definitive diagnosis requires brain biopsy,vitreoretinal biopsy,or cerebrospinal fluid analysis. Survival rates in clinical studies have improved over the past 20 years due to the addition of high- dose methotrexate- based chemotherapy regimens to whole- brain radiotherapy. Long- term survival,however,is complicated by clinically devastating delayed neurotoxicity. Newer regimens are attempting to reduce or eliminate radiotherapy from first- line treatment with chemotherapy dose intensification. Significant advances have also been made in the fields of pathobiology and treatment,with more targeted treatments on the horizon. The rarity of the disease makes conducting of prospective clinical trials challenging,requiring collaborative efforts between institutions. This review highlights recent advances in the biology,detection,and treatment of PCNSL in immunocompetent patients. | Patrick LB Mohile NA | 2016 | 中华神经外科疾病研究杂志2016，15，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员